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THE work of Ellerman and Bang (1908) and Rous (1911) on a leukaemia and
sarcoma of chickens originally showed that viruses could be involved in the origin
of neoplastic growth. Since then several tumour viruses have been isolated from
birds and frogs, but in mammals, until relatively recently, the only viruses known
to be associated with neoplasms were papilloma in rabbits and some other species,
fibroma inrabbits, and mammarytumoursin mice (Review in Oberling and Guerin,
1954). In 1951, Gross found that spontaneous leukaemia in AK mice could be
transmitted by a virus. This observation has been amply confirmed by others
(Woolley and Small, 1956; Furth et al., 1956; Dulaney et al., 1957; Hays
and Beck, 1958), and in the last few years, viruses have been reported as
responsible for some other types of leukaemia (Graffi, Bielka and Fey, 1956;
Friend, 1957; Schoolman et al., 1957), parotid tumours and sarcomas (Gross,
1953, 1955; Stewart 1955), and various other neoplasms in mice and hamsters
(Stewart et al., 1957, 1958; Eddy et al., 1958a).
The above observations in mammals, except those of Stewart, Eddy et al.,
were made by inoculating supernatants or filtrates from a tumour directly into
a susceptible animal. The experiments were usually only successful if the inocu-
lation was made into a host closely related genetically to the animal from which
the extract was taken, and even under these conditions not all the tumours gave
positive evidence for the presence of a virus. Even as regards the actual isolation
of tumour viruses either from mice or from other mammals, this type of experi-
ment has severe limitations. There may be a low virus content or virus inhibitors
in some tumours. Such experiments by themselves can, of course, also give
little direct information on cell-virus relationships and the mechanisms oftumour
induction.
The basic problems relating to tumour viruses in mammals can be formulated
as follows:
(1) Are viruses involved in the origin of all tumours ? (2) How many types of
viruses exist and to what extent are different types mutants of the same virus ?
(3) How are the viruses transmitted, and what is the most effective means of pre-
venting tumourinduction ? (4) Whatis thenature ofthecell-virus interaction and
to what extent do tumour viruses resemble those of lysogenic systems ? (5) Are
tumour viruses present in all animals ? Can they exist as proviruses that can be
activated, or can they be formed de novo, by the chemical and physical agents
known to induce the formation of tumours ? (6) What is the mechanism of the
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to produce the entire or only part of the neoplastic transformation ? Once the
neoplastic state is produced, is the virus necessary for the maintenance of malig-
nancy ? (7) How is the effectiveness ofthe immune response ofthehostrelatedto
theage difference in susceptibility to tumour induction by viruses ? (8) Canthese
viruses be used for genetic studies, and to establish systems of transduction and
transformation ?
It seems clear that an answer to these questions, which may also be of clinical
importance, can be given only by combining the in vivo and an in vitro analysis,
and such a combined approach has been used in the present studies. It has been
shown by Stewart et al. (1957, 1958) and Eddy et al. (1958a) that virus originating
from a spontaneous lymphatic mouse leukaemia in strain AK can be maintained
in tissue culture, and that when harvested from such cultures it can produce a
variety of tumours in hosts not genetically closely related to the animal in which
the tumour arose. We are indebted to Dr. Sarah Stewart and Dr. Bernice Eddy
for sending us some oftheir line 3919, after it had been passaged twice in monkey
kidney and 16 times in mouse embryo cultures. We have used this material,
which they have termed polyoma virus, for in vitro and in vivo studies, and for
comparison with virus obtained from other sources. We were at first concerned
to establish methods for the in vitro characterization of tumour viruses (Sachs,
Fogel and Winocour, 1959) and these methods have then been used in studies on
tumour virus relationships.
EXPERIMENTAL
Plaques
We have routinely grown the polyoma virus on tissue culture monolayers of
Swiss mouse embryo cells with a medium of0.5 per centlactalbuminhydrolysate in
Earle's saline and 20per cent horse serum. The cultures were grown in petri dishes
in anincubatorwith a humidified atmosphere containing 10 per cent CO2. The first
culture of the material received from Stewart and Eddy showed a clear cyto-
pathogenic effect (CPE) under our conditions of growth of the mouse embryo
cells, and a CPE with this virus has also recently been reported by Eddy et al.,
(1958b). As a result ofthe CPE the cells become granular, degenerate, and detach
from the glass often in grape-like clusters. A CPE in vitro was also produced with
this virus on two tissues from adults that were tested-mouse kidney and mouse
bone marrow. By ultilising this effect on the cells in culture it has been possible
to develop a plaque assay for this virus (Sachs, Fogel and Winocour, 1959)
similar to that originally developed by Dulbecco and Vogt (1954) for viruses such
as poliomyelitis. The generalised CPE was localised into foci under agar and the
plaques appeared as small discrete foci of degenerate cells (Fig. 1).
The development of plaques makes possible a quantitative analysis of cell-
virus relationships and the production of pure lines of virus.
Haemagglutination
We have also observed, as recently reported by Eddy et al. (1958c), that
haemagglutination by the polyoma virus takes place at refrigerator (4°C) temper-
ature. It does not haemagglutinate at room or higher temperatures. The virus
has a specific spectrum ofagglutinability with red blood cells (RBC) from different
species (Sachs, Fogel and Winocour, 1959). Because of their availability guinea-ANALYSIS OF TUMOUR VIRUSES
pig cells have been used for routine purposes. The pattern method was used and
the tests read after 3 hours or overnight. 0.15 c.c. of a 1 per cent suspension of
RBCs in saline was added to 0.5 c.c. of each dilution of virus, and the highest
dilution giving a full agglutination of the RBCs (+++-) was used as the end
point. Ifthe tubes are taken from therefrigerator afteragglutination has occurred
and placed at room temperature, the agglutination is destroyed. In experiments
on elution and re-adsorption of the virus it was found that the virus elutes
readily at 37°C, and that after elution the RBCs can again adsorb virus so that
the receptors have not been destroyed. Temperature tests on the stability of the
haemagglutinating particles showed that there is still full agglutination after 30
minutes at 56°C but almost none after 30 minutes at 66°C (Table I).
Haemagglutination inhibition was produced by antisera, and inhibition tests
were carried out using 0.25 c.c. of antiserum, previously heated at 56°C for 30
minutes, and 0*25 c.c. of virus dilution containing 8 or 16 haemagglutinating
units of virus. The virus-antiserum mixture was incubated for 30 minutes at
370 C.
In vitro analysis of the growth ofpolyoma
With the establishment of the plaque and haemagglutination techniques, it
has become possible to make quantitative in vitro analyses on the growth of
mammalian tumour viruses. Some experiments with the polyoma using these
techniques have already been reported (Sachs, Fogel and Winocour, 1959), and
these have shown: (a) that the virus multiplies in tissue culture, (b) that virus is
released over a long period oftime, (c) that a significant amount ofvirusproduced
remains cell associated and is not immediately released into the medium, and
(d) thatthedata obtained by plaques follows that obtainedbyhaemagglutination.
The situation found in (c) is similar to that observed with viruses suchasvaccinia
(Overman and Tamm, 1957) and sheep pox (Plowright and Ferris 1958).
Additional data in support of these conclusions have been obtained with the
polyoma. A further replicate of "total virus" in Experiment 1 (Sachs, Fogel
and Winocour, 1959) has given haemagglutination titres of 1 : 8, 128, and 256
for days 1, 5 and 7 afterinfection. A plaque assay of" total virus "in Experiment
2, Series 2, has confirmed the haemagglutination data in showing that "free
virus " was less than "total virus" throughout the experiment.
Virus of tumoursfrom Gross
In order to study the characteristics of viruses that may be similar to the
polyoma but that have never previously been in tissue culture, we have used
virus from leukaemic mice obtained from Dr. Ludwick Gross. Dr. Gross kindly
sent us some C3HGr mice that had developed leukaemia as a result ofinoculation
with his potent strain A virus (Gross, 1957). This strain, which produces primarily
leukaemia in C3HGr mice, was developed by him by 14 successive inoculations
into newborn C3HGr after its original isolation from a spontaneous lymphatic
leukaemia in an AK mouse.
In order to study virus from this source in vitro, Swiss mouse embryo mono-
layers were inoculated with suspensions of (1) thymus, lymph nodes and spleen,
and (2) brain, (from a leukaemic C3HGr mouse) using our standard culture
medium. The suspensions were prepared by hand homogenisation after the organs
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had been stored at- 20°C for 12 days. As a control, parallel cultures were
inoculated with suspensions of thymus, lymph nodes and spleen, prepared in
the same way, from two normal C3HGr mice that had also been sent to us by Dr.
Gross.
In the first tissue culture passage, the medium was sampled at 3, 7 and 15 days
after incubation, and already in this original passage the cultures inoculated with
the leukaemic thymus, lymph nodes and spleen, gave a haemagglutination titre
of 1: 512 with guinea-pig RBCs, and a CPE on day 15. The 15-day fluid was
used for a second passage and this gave a haemagglutination titre of 1:1024
on day 6 and a CPE on day 7. No haemagglutination or CPE was observed during
these first two passages either in the cultures inoculated with brain from the leuk-
aemic mouse or in those inoculated with organ suspensions from normal mice.
Using haemagglutination, three tests showed a similarity between this virus and
the polyoma. (1) It had a similar spectrum of agglutination with RBCs from
different species, (2) it had a similar temperature stability at 56°C and 66°C
(Table I), and (3) it was neutralised by antibodies against polyoma and vice versa
(Table II).
These experiments therefore demonstrate (a) that there is a strong similarity
between virus obtained from the two sources, (b) that a CPE can be obtained in
thefirstpassage inculture, and (c) that at least as regards this tumour, brain is not
a better source of virus than the leukaemic organs. It should be noted that the
original isolation ofvirus by Gross, and that of Stewart and Eddy which has now
been in culture for at least 20 passages, were both made from spontaneous
lymphatic leukaemia in AK mice.
Virusfrom chloroleukaemia
In addition to the material from lymphatic leukaemia, we have used extracts
from a chloroleukaemia in mice. Dr. A. Graffi kindly sent us some mice (passage
SOV 16) that had developed chloroleukaemia as a result of inoculation with a
virus that had originally been isolated by him from the Ehrlich tumour (Graffi,
Bielka and Fey, 1956). Using our standard medium, Swiss embryo monolayers
were inoculated with suspensions of(1) lymph nodes andspleen, and (2) brain, from
a leukaemic mouse with markedly green lymph nodes. The suspensions were made
by hand homogenisation of organs that had been stored at - 20°C for 11 weeks.
This material has now been through four passages in culture without any CPE.
There was also no haemagglutination either by the medium or by extracts from
cells of the culture. This virus, therefore, seems to behave differently in culture
than that isolated from mice with spontaneous lymphatic leukaemia.
The induction of tumours by the polyoma virus and the production of virus by the
tumour cells
The in vivo tumour inducing action of the polyoma was tested by inoculating
newborn (less than 24 hours old) Swiss mice intraperitoneally or subcutaneously
with 0.1 c.c. or 0.05 c.c. of virus taken from tissue culture, and we have observed,
as also reported by Stewart et al. (1957, 1958) the induction of a great variety of
tumours. Not all the tumours have yet been histologically analysed, but the most
frequent sofarencountered arekidney sarcomas, mucousglandtumours, mammary
carcinomas, and hair follicle tumours. The Swiss mice used for these experiments,ANALYSIS OF TUMOUR VIRUSES
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and for the tissue cultures, are derived from an inbred line that has been brother-
and-sister mated for at least 20 generations.
From our first passage of polyoma in culture, newborn Swiss were inoculated
with tissue culture fluid harvested at 14, 21 and 28 days after infection of the
monolayers. All three fluids produced tumours, despite the destruction of nearly
all the cells of the monolayers by CPE at 28 days. A mouse, 13 weeks after
inoculation with 14-day fluid is shown in Fig. 4, and a mouse, 11 weeks after
inoculation with another fluid, in Fig. 2. Of the animals that survived more than
one month after inoculation with various fluids, 61 out of 68 mice in a total of
17 litters have developed tumours in an observation period of 5 months. The
earliest palpable tumours generally appeared at about 2 months after inoculation.
In addition to inoculation into newborn mice, one litter of four Swiss 7 days
old, and one litter of four Swiss 14 days old were inoculated intraperitoneally
with 0.1 c.c. of our first 14-day tissue culture fluid. Two of the four mice inocu-
lated at 7 days of age have developed tumours in an observation period of 5
months, whereas no tumours have developed in this period in the 14-day old mice.
The polyoma can therefore produce tumours in mice inoculated 7 days after birth,
although the latency period for the earliest palpable tumours in these animals
was 31 instead ofthe usual 2 months. No tumour has developed in an observation
period of 5 months in 50 Swiss mice inoculated as adults.
One litter of six newborn albino rats was inoculated with polyoma. Three
survived morethanone monthand ofthese one developed sarcoma inbothkidneys
(Fig. 5) two months after inoculation.
There was a high early mortality in newborn mice inoculated with virus
containing fluids, and those that survived frequently became dwarfed. In addition
to dwarfing the affected animals showed a characteristic closure of the eyes.
The difference between two litter mates, only one of which was inoculated with
virus is shown in Fig. 3. The affected mice would either remain dwarfed and
develop tumours, or recover from the drawfing and develop tumours later on.
Since the virus can induce tumours, itis obviously of interest to determine
to what extent the cells of tumours induced with polyoma are able to produce
virus. Extracts of tumours made by homogenisation with a motor driven homo-
geniser from five different mice did not give haemagglutination. Tumours were
therefore trypsinised and the cells placed into culture using our standard medium.
The cell inoculum was 10-12 x 106 cellsper petri dish and the medium was tested
by haemagglutination at various intervals after seeding. The results of four
experiments from four different tumours are given in Table III, and they clearly
show that tumour cells can produce virus under these conditions. It should be
pointed out that with the medium used there was little or no growth ofthe tumour
cells in culture, and the cells eventually degenerate.
EXPLANATION OF PLATES
FIG. 1.-Plaques produced by polyoma virus on mouse embryo tissue culture. X 40.
Fig. 2 and 4.-Multiple tumours (someofwhich are shown by arrows) in Swiss mice inoculated
with polyoma virus.
FIG. 3.-Two Swiss litter mates eight weeks old, showing a non-inoculated mouse and dwarfing
of the litter mate inoculated with polyoma virus.
FIG. 5.-Rat with kidney tumours induced by polyoma virus.BRrrisifr JOULRNAL OF CANCER.
Sachs, Fogel, Winocour, Heller, Medina and Krim.
Vol. XIII, No. 2.BRITISH JOURNAL OF CANCER.
Sachs, Fogel, Winocour, Heller, Medina and Krim.
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TABLE III.-Production of Virus by Turnour Cells in Culture
Experiment Days in Haemagglutination
No. culture titre 1:
1 . 1 . -*
3
7 128
2 . 8 . 128
11 . 128
3 4
8 . 1024
4 4
8 . 2048
10 . 2048
* --= Not higher than the control of normal time culture medium.
Cytopathogenic effect and tumour induction
The existence of (1) a CPE that produces cell death, and (2) tumourinduction,
raises the question to what extent these represent different reactions of cells to
infection with the same virus. In order to answer this question it was first neces-
sary to determine ifboth the CPE and the tumour are produced by the same virus.
It has already been shown in the section on virus from Gross, that even the first
passage in culture of virus from a tumour can produce a CPE. This has been
further substantiated by tests made with two ofthe isolations shown in Table III.
Swiss embryo monolayers were infected with the 7-day fluid from Experiment 1,
and the 8-day fluid from Experiment 3, and both these isolations, made directly
from tumour cells, gave a CPE in the first passage. No long period of adaptation
is thus essential with this virus in order to produce a CPE on embryo cells in
culture.
Neutralisation tests have given further evidence in favour of the suppositionll
that both the CPE and the tumour are produced by the same virus. Antibodies
in serum taken from tumour-bearing mice (see next section) must have been
produced by the tumour-inducing virus, andit has beenfound that such antibodies
can neutralise plaque formation by polyoma (Table IV). Such serum can also
TABLE IV.-Inhibition of Plaque Formation by Serumfrom Tumour-bearing Mice
Average number of plaques
per platet
Experiment 1 Virus plus antiserum 1: 10 . 53
Virus plus normal serum 1::10 . 115
Virus plus saline* . 116
Experiment 2 . Virus plus antiserum 1: 10 . 0
1:50 13
1:250 . 18
1:1250 . 42
Virus plus normal serum 1 : 10 . >200; confluent
1:50 . >200; confluent
1:250 . >200; confluent
1:1250 . >200; confluent
Virus plus saline . >200; confluent
Neutralisation: Virus plus serum mixed 1: 1 and held at 37°C for 1 hour in Experiment 1 and
for 4 hours in Experiment 2.
* Earle's saline plus 0.5 per cent lactalbumin hydrolysate.
t Average of 4 replicate plates in Experiment 1; and of 3 replicate plates in Experiment 2.
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neutralise the haemagglutinating particles. This demonstrates that virus that
can produce CPE in vitro is neutralised by antibodies against virus that produces
tumours in vivo. As has already been pointed out in the previous section, virus
harvested after CPE produces tumours.
The high early mortality in young virus-injected mice, and the dwarfing
effect in these mice after injection, furthermore suggest that a necrotic action of
the virus may also occur in vivo. It thus seems that both an eventual death and
a cell proliferating action can be produced by the same virus, and there is some
evidence, which is now being studied quantitatively, that the polyoma can
produce cell proliferation in vitro before CPE. It could be postulated that after
virusinfection a cell-virus relationship is established thatchanges therequirements
of the infected cells and that if these new requirements are not met, e.g. as in
the tissue culture medium used by us, the cells will degenerate, i.e. a CPE will
be produced.
These results with the polyoma therefore provide an experimental analogy
to the original observation of Duran-Reynals (1940) on the haemorrhagic disease
produced by fowl tumour viruses. A CPE on cells in culturehas also been reported
for the virus of avian lymphomatosis (Sharpless, Defendi and Cox, 1958; Fontes
et al., 1958), and the possibility either of growth stimulation or degeneration as
a result ofinfection withthe same virus has been observed on the chorioallantoic
membrane after infection with the Rous chicken virus (Prince, 1958) and with
vaccinia (Overman and Tamm, 1957).
Theproduction ofantibodies in newborn, adult and tumour-bearing animals
Experiments on immunological tolerance have shown that the antibody-
forming system in mice begins to function at about the time ofbirth (Billingham,
Brent and Medawar, 1956), and it was therefore of interest to determine to what
extent this is related to the age difference in susceptibility to tumour induction
by virus. Using haemagglutination inhibition as a measure of the amount of
antibody produced against the polyoma, it has been found that the response to
virus infection differs in newborn and adult mice, and that this is reflected in a
difference in the induction period before antibodies can be detected (Table V).
In adults antibodies could be detected four days after inoculation whereas in
newborn inoculated mice in this experiment, the titre was no higher than the
control even at eight days. Tests made at later intervals after inoculation have
shown that haemagglutination inhibition antibodies have always eventually been
produced in mice inoculated as newborn (Table VI) and that there can be high
titres even before any palpable tumours are observed. Particularly high titres
have however been found in the animals with tumours
These data thus demonstrate that the high susceptibility of newborn mice to
tumour induction, does not seem to be due to the production of a state of
immunological tolerance to the virus.
It has been shown in a previous section that tumour cells are able to produce
virus, and the high titres in the tumour-bearing mice are presumably due to this
liberation of virus by cells of the growing tumour. Since the tumours continue
to grow despite the presence of high titres of antibody, these data also indicate
that antibodies produced against the virus are not effective in preventing the
progressive growth of the tumour cells.ANALYSIS OF TUMOUR VIRUSES
TABLE V.-Induction Period in Newborn and Adult Swiss Mice Inoculated
with Virus
Days after
inoculation
1
2
3
4
5
7
Age of mous
at inoculatioi
Adult
Newborn
Adult
Newborn
Adult
Newborn
Adult
Newborn
Adult
Newborn
Adult
Newborn
Adult
Newborn
All mice inoculated subcutaneously with
titre 1: 256.
NT = not tested.
* Different mice tested each day.
Haemagglutination-
De inhibition Number of
n titre 1: sera tested*
40 . 3 pooled
* NT
20 . 3 pooled
* NT
10 . 3 pooled
* NT
80 . 3 pooled
40 . 20 pooled
320 . 3 pooled
20 18 pooled
320 3 pooled
20 . 6 pooled
2560 . 3 pooled
40 . 8pooled
0'05 c.c. of polyoma virus with a haemagglutination
TABLE VI.-Haemagglutination Inhibition Titres at Various Intervals
after Inoculation of Virus into Newborn Swiss Mice
Time (in weeks)
after inoculation
2
2
3
3
4
4
5
13
13
14
20
22
22
22
22
+ = present.
- = absent.
Number of
mice tested
2 pooled
7 pooled
2 pooled
2 pooled
2
1
2
2
1
1
2
1
1
1
1
Titre 1:
320
1,280
640
2,560
2,560
10,240
5,120
>20,480
40,960
20,480
>5,120
>10,240
>20,480
40,960
>40,960
Palpable
tumours
+
+
+
+ +
+
Although the age difference in susceptibility thus does not seem to be due to
immunological tolerance, it may still be due to the ability of the virus to multiply
and re-infect other cells when inoculated into newborn, to a much greater extent
than when inoculated into adults, and this point is being more fully investigated.
A comparison of mice inoculated shortly after birth with virus, adult kidney cells
followed by virus, and adult spleen cells followed by virus, has shown that at six
weeks after virus infection, animals inoculated with the adult antibody-forming
cells (spleen) and virus have a significantly greater percentage of survival and
marked lack of dwarfing, in comparison to mice inoculated only with virus or
with adult kidney cells (i.e. non-antibody-forming cells) and virus.
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Antibodies in animals that develop spontaneous tumrnours
The finding of high antibody titres before palpable tumours can be observed,
and even high titres in mice with obvious tumours, suggested the possibility that
such asituation mayalso existinanimalswhich have not beenpurposelyinoculated
with virus, but which are knownto develop spontaneous tumours. Haemagglutina-
tion inhibition tests with polyoma virus have therefore been made on mice of
different ages belonging to the high leukaemic strain AKR, and the results are
given in Table VII. None of 16 mice less than 23 weeks old had antibody levels
higher than the control value, whereas 8 out of 12 mice more than 32 weeks old
had considerable antibody titres against this virus. Tests on 20 Swiss mice, 34
to 56 weeks old and 20 C57BL mice 56 to 60 weeks old, have all shown no haem-
agglutination inhibition in excess of the control value found in younger animals.
TABLE VII.-Haemagglutination Inhibition Tests with AKR Mice
Age Number of
in weeks tests* Titre 1:
13 . 6 20
15 . 1 10
15 . 5 . 20
17 . 2 . 20
23 . 2 . 20
32 . 1 . 320
32 . 1 . 640
32 4 . 1280
34 . 1 . 20
34 . 1 . 1280
35 . 2 . 20
36 . 1 . 10
36 . 1 . 2560
*Each test represents the result from a different mouse.
These data show that AKR mice can carry the polyoma, and furthermore
that the detection of antibodies may be a useful guide (a) to the existence of
tumour virus in animals, and (b) to the eventual development of tumours. The
absence of high titres in four of the other older AKR suggests either that these
animals will not develop tumours, or that although a high antibody titre may
frequently be correlated with eventual tumour development, this correlation may
perhaps not exist in every animal. The existence of antibodies is therefore being
further studied in relation to histological examination ofthe tissues for malignancy
in AKR, and in animals that develop other types oftumours.
In addition to the experiments on AKR, haemagglutination inhibition tests
were made with serum from seven C3H mice with large and five with small
spontaneous mammary tumours. Of these four with large tumours showed anti-
body titres of 1: 80, 320, 1280, and 2560 respectively. Some C3H mice may
therefore also carry the polyoma, and since the C3H used was known to carry
the mammary tumour virus (milk agent), there may perhaps be some relation-
ship between the mammary virus and polyoma.
The transmission ofpolyoma virus
One of the basic questions relating to tumour viruses is how the viruses are
transmitted. In order to obtain information on this point, experiments wereANALYSIS OF TUMOUR VIRUSES
carried out with thepolyoma on the possibility of virus transmission. (1) between
litter mates, (2) from virus injected litters to their mother, and (3) from a virus
injected mother to her litter. Haemagglutination inhibition was used as a test
for the presence ofvirus. The results are given in Table VIII, and the data clearly
show that virus can be transmitted under all three conditions. It should be noted
that in all these tests both the injected and non-injected animals were kept in
the same cage. In the experiment in which non-injected animals were kept in
the same room but in a different cage (Table VIII) there has so farbeen no evidence
of virus transmission. We have also so far found no haemagglutination inhibition
antibodies in the sera ofthe people who have been in contact with the polyoma in
the tissue culture, haemagglutination, and animal experiments.
TABLE VIII.-Virus Transmission in Swiss Mice
Number of
mice
3 pooled
5 pooled
1
1
1
1
1
1
1
1
1
3 pooled
5
Source of infection
Newborn litter mates inoculated
i.p.*
Mother ineculated i.p. 16th day of
pregnancy
Litter inoculated s.c.
Litter inoculated s.c. and i.p.
Litter inoculated s.c. and i.p.
Litter inoculated s.c.
Litter inoculated i.p.
Litter inoculated i.p.
Litter inoculated s.c.
Litter inoculated i.p.
Litter inoculated i.e.
Inoculated with normal tissue cul-
ture medium asnewborn andkept
in same room as virus-inoculated
mice
None
Haemag-
Tested (days) glutination
after inhibition
contact titre 1:
45 . 1280
27 . 320
15
15
15
21
37
50
50
50
50
59
20
20
20
80
80
320
640
640
640
40
40
*i.p. -= Intraperitoneal, s.c. = subcutaneous, and i.c. -= intracranial.
It can thus be seen that a tumour virus can be transmitted under certain
conditions from animal to animal, and the exact route of infection, i.e. whether
from urine, faeces, saliva, milk, transplacental, etc., can now be tested.*
The isolation of virusfrom human tumours
The results described above suggested that by using a similar in vitro and
in vivo approach it may be possible to determine the role of viruses in the origin
of human tumours. The methods developed for the mouse are therefore being
applied to material from patients. In order to avoid contamination, the experi-
ments are being carried out by one of us in a separate tissue culture cubicle,
at a time when he is not handling virus isolated from mice. Human material has
been inoculated onto monolayers of Swiss mouse embryos using our standard
medium. Cultures consisting of bone marrow from two patients (one with
* Note added in proof. Isolations from five animals have shown that the polyoma can be excreted
in the faeces, urine and saliva.
from:
culated
mates
,culated
Serum f
Non -ino
litter r
Non -ino
litter
Mother
Adult
Control
,,9
,,9
,,.
Adult
Control
261262 SACHS, FOGEL, WINOCOUR, HELLER, MEDINA AND MATHILDE KRIM
myeloid and one with stem cell leukaemia) on Swiss embryo cells have given an
effect on the cultures, and the in vivo tumour-inducing activity of this material
is now under examination.
DISCUSSION
It can be seen from the above results, that by combining an in vitro with an
in vivo approach, experimental systems can be established in order to answer
some of the basic problems relating to the role of viruses in the origin of mam-
malian tumours. In addition, the establishment of these systems is also ofvalue
for the actual isolation and characterisation of tumour viruses.
The development ofthe plaque and haemagglutination techniques has made it
possible to begin a quantitative analysis of cell-virus relationships, which is a basic
pre-requisite for an understanding, at the cellular level, of the role of viruses in
tumour formation. For this study, the growth of polyoma on mouse embryo
monolayers has been used as a model. The finding in this system that a cyto-
pathogenic effect in vitro and tumour induction in vivo are produced by the same
virus, shows that infection with tumour virus can produce under different condi-
tions either growth stimulation or eventual cell degeneration.
The use of in vitro tests such as haemagglutination inhibition, has shown that
these tests can readily provide information on the presence of tumour virus in
an animal, the development of tumours induced by virus, and the transmission
of virus from one animal to another.
One of the questions raised in the present studies is the relationship between
leukaemia, polyoma, and mammary tumour virus (milk agent), and whether a
single or a group of viruses is involved in the origin of multiple tumours. It has
been shown that there is a strong similarity between the virus obtained from
Gross and polyoma. In addition, the findings (1) thathigh antibody titres against
polyoma can exist in some C3H mice (known to carry the mammary tumour
virus) with spontaneous mammary tumours, and (2) that a high frequency of
mammary carcinomas is induced in Swiss mice inoculated with the polyoma,
suggest that some C3H mice may carry the po]yoma and that this virus mayper-
haps be related to the mammary tumour virus. The observation of Gross (1955)
that extracts from normal C3H tissues can induce parotid tumours and subcuta-
neous sarcomas when inoculated into newborn C3H mice, also suggests that C3H
may carry the polyoma. The fact that the mammary tumour virus cultured on
plasma clots with chick fibroblasts (Pikovski, 1953) produced under these condi-
tions only mammary tumours in C57BL mice and C57BL and RIII hybrids, does
not necessarily rule out a relationship between this virus and the polyoma.
The conditions of the culture system, and possibly even the test animals, may
not have been the best to demonstrate the full potentialities of the virus after
passage in culture. Mammary tumour virus is therefore being cultured using the
same conditions as for the polyoma.
Since with the development ofthe plaque technique it is now possible to isolate
pure lines of virus from different tumours, such isolations are being tested for
the types of tumour that they produce in animals. The use of such pure lines in
in vivo infection experiments should be able to demonstrate conclusively to what
extent mammary tumours, leukaemia, and other types of tumours are produced
by the same mutants, or quite different strains of virus. The establishment of
such pure lines could also provide material for a genetic analysis of these animalANALYSIS OF TUMOUR VIRUSES
viruses. The plaque isolates will thus be able to show to what extent the situation
in mice resembles that in chickens where various types of tumours seem to be
produced by a group ofrelated viruses (Beard, 1957).
It has been shown that tumour cells can produce virus and this has been
demonstrated by placing the cells in culture. This technique may have the
additional advantage of providing the most satisfactory method of isolating
virus from different tumours and it is now being applied to the studies on humans.
In addition, these results suggest that there exists in these tumours some stable
form of cell-virus relationship. Evidence for such a relationship has also been
obtained for the Rous chicken virus (Rubin, 1955), and it also seems to exist in
avian myeloblastosis (Beaudreau et al., 1958). This raises the further possibility
that mammalian tumour viruses may prove to be of value for the study of
transduction of genetic characters, e.g. antigens, in mammalian cells where there
already exist some good genetic markers. There may also exist some further
analogues to the fibroma-myxoma transformation (Kilham, 1958). The study of
mammalian tumour viruses may therefore be of value not only for an under-
standing of the origin of tumours, but also for an understanding of some other
basic properties of viruses and cells.
SUMMARY
1. A combined in vitro and in vivo analysis has beeen made ofvirus (virus from
Gross and polyoma virus) originally isolated from mice with spontaneous lym-
phatic leukaemia. An in vitro study has also been made of a virus from a chloro-
leukaemia in mice. The in vitro analysis has been based on the use of tissue
culture monolayers and the development of a plaque and haemagglutination
technique. These techniques make possible a quantitative in vitro analysis of
tumour virus relationships, and the development of plaques further makes pos-
sible the production of pure lines ofvirus. In vitro methods can also be applied
to the study of human tumours.
2. Using the growth of polyoma on mouse embryo monolayers as a model
system, it has been shown that the virus multiplies in tissue culture, that virus is
released over a long period of time, that a significant amount of virus produced
remains cellassociated, andthatthe dataobtainedbyplaquesfollowsthat obtained
by haemagglutination.
3. Studies on virus from Gross have demonstrated that there is a strong
similarity between a virus from this source and the polyoma, and that at least as
regards this tumour, brain is not a better source of virus than leukaemic organs.
4. Virus from chloroleukaemia seems to behave differently in culture than
that isolated from mice with spontaneous lymphatic leukaemia.
5. The polyoma when inoculated into newborn Swiss mice produced a range of
tumours, the most frequent so far being kidney sarcomas, mucous gland tumours,
mammary carcinomas, and hair follicle tumours. The earliest palpable tumours
usually appeared about 2 months after inoculation, and in an observation period
of 5 months, tumours developed in 90 per cent (61/68) of the inoculated mice.
Tumours with a longer latent period were produced in two Swiss mice inoculated
at seven days ofage, but none in mice inoculated at fourteen days or later. Kidney
sarcomas were found two months after inoculation of virus into a newborn rat.
6. Studies on tumour cells in culture have shown that malignant cells can
produce virus.
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7. It has been shown that a cytopathogenic effect on cells in vitro, and tumour
induction in vivo, are produced by the same virus.
8. Studies on the immune response of the host have shown that the high
susceptibility of newborn animals does not seem to be due to the induction of a
state of immunological tolerance to the virus. All animals inoculated as new-
born eventually develop haemagglutination inhibition antibodies (even before
observable tumours) and such antibody titres are particularly high in animals with
palpable tumours.
9. AKR mice of different ages (which were not inoculated with virus) were
tested for haemagglutination inhibition antibodies against polyoma. None of
16 mice less than 23 weeks old had significant levels of antibody, whereas 8 out
of 12micemorethan 32 weeks oldhad considerable antibody titres. Thishasshown
that AKR mice carry the polyoma, and that the detection ofantibodies maybe a
useful guide to the existence of tumour viruses, and possibly also to the eventual
development of tumours.
10. No significant haemagglutination inhibition titres were found in 20 normal
Swiss mice 34 to 56 weeks old or in 20 C57BL mice 56 to 60 weeks old.
11. Studies on the transmission of the polyoma have shown that the virus
can be transmitted from inoculated to non-inoculated litter mates, from an
inoculated mother to her non-inoculated litter, and from an inoculated litter to
their non-inoculated mother.
We are very much indebted to the Winfield Baird Foundation for a grant in
support of this work.
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